Read Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

Robert Bazell

4.9/5 (14292 ratings)

Description:Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free.Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers.Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer. To get started finding Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer, you are right to find our website which has a comprehensive collection of manuals listed.
Our library is the biggest of these that have literally hundreds of thousands of different products represented.

Pages: 473

Format: PDF, EPUB & Kindle Edition

Publisher: N/A

Release: 1998

ISBN: 0812991842

Description: Two years after she underwent a mastectomy and chemotherapy, Barbara Bradfield's aggressive breast cancer had recurred and spread to her lungs. The outlook was grim. Then she took part in Genentech's clinical trials for a new drug. Five years later she remains cancer-free.Her-2 is the biography of Herceptin, the drug that provoked dramatic responses in Barbara Bradfield and other women in the trials and that offers promise for hundreds of thousands of breast cancer patients. Unlike chemotherapy or radiation, Herceptin has no disabling side effects. It works by inactivating Her-2/neu--a protein that makes cancer cells grow especially quickly-- produced by a gene found in 25 to 30 percent of all breast tumors. Herceptin caused some patients' cancers to disappear completely; in others, it slowed the progression of the disease and gave the women months or years they wouldn't otherwise have had. Herceptin is the first treatment targeted at a gene defect that gives rise to cancer. It marks the beginning of a new era of treatment for all kinds of cancers.Robert Bazell presents a riveting account of how Herceptin was born. Her-2 is a story of dramatic discoveries and strong personalities, showing the combination of scientific investigation, money, politics, ego, corporate decisions, patient activism, and luck involved in moving this groundbreaking drug from the lab to a patient's bedside. Bazell's deft portraits introduce us to the remarkable people instrumental in Herceptin's history, including Dr. Dennis Slamon, the driven UCLA oncologist who played the primary role in developing the treatment; Lily Tartikoff, wife of television executive Brandon Tartikoff, who tapped into Hollywood money and glamour to help fund Slamon's research; and Marti Nelson, who inspired the activists who lobbied for a "compassionate use" program that would allow women outside the clinical trials to have access to the limited supplies of Herceptin prior to FDA approval of the drug. And throughout there are the stories of the heroic women with advanced breast cancer who volunteered for the trials, risking what time they had left on an unproven treatment. Meticulously researched, written with clarity and compassion, Her-2 is masterly reporting on cutting-edge science.We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer. To get started finding Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer, you are right to find our website which has a comprehensive collection of manuals listed.
Our library is the biggest of these that have literally hundreds of thousands of different products represented.

Special Offer | $0.00

Special Offer! | $0.00

Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

Her-2: The Making of Herceptin, a Revolutionary Treatment for Breast Cancer

More Books

Drugs and the FDA: Safety, Efficacy, and the Public's Trust

Drugs and the FDA: Safety, Efficacy, and the Public's Trust

For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug

For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug

Unreasonable Hospitality: The Remarkable Power of Giving People More Than They Expect

Unreasonable Hospitality: The Remarkable Power of Giving People More Than They Expect

Science Lessons: What the Business of Biotech Taught Me About Management

Science Lessons: What the Business of Biotech Taught Me About Management

Genentech: The Beginnings of Biotech (Synthesis)

Genentech: The Beginnings of Biotech (Synthesis)

The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race

The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race

The Breakthrough: Immunotherapy and the Race to Cure Cancer

The Breakthrough: Immunotherapy and the Race to Cure Cancer

Feral: Losing Myself and Finding My Way in America’s National Parks

Feral: Losing Myself and Finding My Way in America’s National Parks

How the Word Is Passed: A Reckoning with the History of Slavery Across America

How the Word Is Passed: A Reckoning with the History of Slavery Across America